ClinicalTrials.govpublic full text
SLM + Axitinib for Clear Cell RCC
advanced metastatic clear cell renal cell carcinoma (ccrcc), kidney cancer, selenium (se), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910572
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.